Register for the Oligonucleotide Therapeutics Regional Meeting – Australia & New Zealand in November
Join leading researchers, clinicians, biotechnology professionals and industry experts working across oligonucleotide and RNA therapeutics for the inaugural Oligonucleotide Therapeutics Society’s Regional Meeting in Perth, Western Australia, 25-27 November 2026.
The Oligonucleotide Therapeutics Society (OTS) Regional Meeting Australia – 2026 stands as a pivotal gathering for the global scientific community. This conference serves as a dedicated platform for researchers, clinicians, and industry leaders to converge on the latest breakthroughs in oligonucleotide therapeutics.
Why Attend OTS Australia 2026?
Join leading researchers, clinicians, biotechnology professionals and industry experts working across oligonucleotide and RNA therapeutics. OTS Australia 2026 will provide an opportunity to discover emerging research, exchange scientific insights, build collaborations and explore the future of RNA-based medicines.
- Hear from leading Australian and international experts.
- Discover advances in oligonucleotide and RNA therapeutics.
- Participate in scientific sessions and panel discussions.
- Connect with researchers, clinicians and industry leaders.
- Explore collaboration, research and commercialisation opportunities.
- Present your research through oral or poster presentations.
There is also the opportunity to submit an abstract for both oral and poster presentations. Five travel grants are also available for early and mid-career researchers and higher degree research students towards flights and accommodation for those presenting. Visit the website.
Conference details
When: 25-27 November 2026
Where: The Ritz-Carlton, Perth, 1 Barrack St, Perth, Western Australia
Early bird registration closes 15 September 2026.
Visit the website to find out more and register
